Cipher Acquiring Innocutis $CPHR $XHS

Cipher Pharmaceuticals Inc. has announced to acquire a US privately held specialty dermatology company, Innocutis Holdings LLC., for 45.5 Million US Dollars cash. The major goal is to enter the US Market and step forward in Dermatology Business. View the full release here.

Cipher Acquiring Innocutis $CPHR $XHS Read More »